Dutch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

infertility/obesitas

De link wordt op het klembord opgeslagen
Bladzijde 1 van 23 resultaten

Methods and systems for assessing infertility and related pathologies

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND According to the Centers for Disease Control and Prevention, 6.7 million women (around 10.9%) in the United States between the ages of 15 and 44 suffer from impaired fecundity, or the ability to become pregnant and carry a baby to term. See Chandra A, Copen C E, Stephen E H. Infertility

Obesity gene

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
CROSS-REFERENCE TO RELATED APPLICATION This application claims priority under 35 U.S.C. .sctn.120 to International Application serial number PCT/GB99/02658, filed Aug. 12, 1999, which claims priority to application serial number GB9910522.3, filed May 6, 1999, and GB9817566.4, filed Aug. 12,

Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
INTRODUCTION The present invention relates to variant forms of the receptor for the obese gene product. In particular, the invention relates to methods of detecting receptor variants in the reproductive organs for the diagnosis of the cause of infertility. In addition, it relates to methods of

Organic compounds

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
The present invention relates to novel imidazole derivatives that are used as aldosterone synthase and aromatase inhibitors, as well as for treatment of a disorder or disease mediated by aldosterone synthase or aromatase. The present invention provides a compound of formula (I) ##STR00002## wherein

Organic compounds

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
The present invention relates to novel imidazole derivatives that are used as aldosterone synthase and aromatase inhibitors, as well as for treatment of a disorder or disease mediated by aldosterone synthase or aromatase. The present invention provides a compound of formula (I) ##STR00002## wherein

Organic compounds

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
The present invention relates to novel imidazole derivatives that are used as aldosterone synthase and aromatase inhibitors, as well as for treatment of a disorder or disease mediated by aldosterone synthase or aromatase. The present invention provides a compound of formula (I) ##STR00002## wherein

SnoRNA, compositions and uses

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
CROSS-REFERENCE TO RELATED APPLICATION This application is the U.S. national stage application of International Patent Application No. PCT/EP2014/073991, filed Nov. 7, 2014. The Sequence Listing for this application is labeled "Seq-List-replace-2.txt" which was created on Sep. 15, 2017 and is 13 KB.

Substituted benzopyrans as selective estrogen receptor-beta agonists

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION The present invention relates to novel benzopyran ER-.beta. agonist compounds, pharmaceutical compositions thereof, and use of these compounds to treat a ER-.beta. mediated disease such as benign prostatic hypertrophy, obesity, dementia, hypertension, incontinence, colon
FIELD OF THE INVENTION This invention relates to the fields of molecular biology and pharmaceutical research. More specifically, this invention relates to the identification and recombinant expression of two new genes, cyclic nucleotide gated channel-15 (CNGC-15) and Myosin IXa. Accordingly,

Synthesis of 3,3,4,4-tetrafluoropyrrolidine and novel dipeptidyl peptidase-IV inhibitor compounds

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF INVENTION The present invention relates to a method of making novel dipeptidyl peptidase-IV ("DPP-IV`) inhibitor compounds and a method of making 3,3,4,4-tetrafluoropyrrolidine, a starting material utilized in the afore-mentioned method for preparing DPP-IV compounds. BACKGROUND OF

Modulation of substance P by compounds containing calcium sulfate and methods relating thereto

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
TECHNICAL FIELD The present invention relates generally to a method of modulating substance P by compounds containing calcium sulfate, particularly syngenite, gorgeyite and gypsum, and more specifically, to the synthesis of such compounds as well as their use to treat a variety of conditions

Modulators of ob gene and screening methods therefor

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF THE INVENTION This invention relates to a method for screening for agents useful for treatment of diseases and pathological conditions affected by ob genes, and agents and compositions identified using such screening method. This invention also relates to regulatory elements and promoter

Pyridone derivatives

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
This application is a U.S. national stage of International Application No. PCT/JP03/03115 filed Mar. 14, 2003. TECHNICAL FIELD The present invention is useful in medical fields. In more detail, novel pyridone derivatives of the present invention have an effect as neuropeptide Y receptor antagonists

Leptin agonist and methods of use

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF THE INVENTION The invention relates to leptin peptide fragments and their use as agonists of the leptin receptor. BACKGROUND OF THE INVENTION Leptin is a neurohormone that acts in the hypothalamus to regulate energy balance and food intake (M. Wauters, et al., Eur. J. Endocrinol., 2000,

Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to aminoalkyl substituted 5,6,7,8-tetrahydro-9H-pyridino[2,3-b]indole and 5,6,7,8-tetrahydro-9H-pyrimidino[4,5-b]indole derivatives, pharmaceutical compositions containing such compounds and their use in treating
Word lid van onze
facebookpagina

De meest complete database met geneeskrachtige kruiden, ondersteund door de wetenschap

  • Werkt in 55 talen
  • Kruidengeneesmiddelen gesteund door de wetenschap
  • Kruidenherkenning door beeld
  • Interactieve GPS-kaart - tag kruiden op locatie (binnenkort beschikbaar)
  • Lees wetenschappelijke publicaties met betrekking tot uw zoekopdracht
  • Zoek medicinale kruiden op hun effecten
  • Organiseer uw interesses en blijf op de hoogte van nieuwsonderzoek, klinische onderzoeken en patenten

Typ een symptoom of een ziekte en lees over kruiden die kunnen helpen, typ een kruid en zie ziekten en symptomen waartegen het wordt gebruikt.
* Alle informatie is gebaseerd op gepubliceerd wetenschappelijk onderzoek

Google Play badgeApp Store badge